IGF2BP2 and metabolic dysfunction-associated steatohepatitis: Animal studies suggest that p62 promotes NASH progression by driving hepatic iron deposition and free cholesterol production, which in turn lead to lipid peroxidation and inflammation via NF-κB activation [110].